Page last updated: 2024-11-01

niclosamide and Cells, Neoplasm Circulating

niclosamide has been researched along with Cells, Neoplasm Circulating in 3 studies

Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.

Research Excerpts

ExcerptRelevanceReference
" Further, encapsulation of NCS improved its effectiveness in vitro, particularly against colonspheres, and allowed to increase its intravenous dosage in vivo by increasing the amount of NCS able to be administered without causing toxicity."5.62Polymeric micelles targeted against CD44v6 receptor increase niclosamide efficacy against colorectal cancer stem cells and reduce circulating tumor cells in vivo. ( Abasolo, I; Andrade, F; Arango, D; Boullosa, A; Cámara-Sánchez, P; Díaz-Riascos, ZV; García-Aranda, N; Martínez-Trucharte, F; Montero, S; Nestor, M; Rafael, D; Sarmento, B; Schwartz, S; Seras-Franzoso, J; Vilar-Hernández, M, 2021)
" Further, encapsulation of NCS improved its effectiveness in vitro, particularly against colonspheres, and allowed to increase its intravenous dosage in vivo by increasing the amount of NCS able to be administered without causing toxicity."1.62Polymeric micelles targeted against CD44v6 receptor increase niclosamide efficacy against colorectal cancer stem cells and reduce circulating tumor cells in vivo. ( Abasolo, I; Andrade, F; Arango, D; Boullosa, A; Cámara-Sánchez, P; Díaz-Riascos, ZV; García-Aranda, N; Martínez-Trucharte, F; Montero, S; Nestor, M; Rafael, D; Sarmento, B; Schwartz, S; Seras-Franzoso, J; Vilar-Hernández, M, 2021)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Hochmair, M1
Rath, B1
Klameth, L1
Ulsperger, E1
Weinlinger, C1
Fazekas, A1
Plangger, A1
Zeillinger, R1
Hamilton, G1
Hilfenhaus, G1
Mompeón, A1
Freshman, J1
Prajapati, DP1
Hernandez, G1
Freitas, VM1
Ma, F1
Langenbacher, AD1
Mirkov, S1
Song, D1
Cho, BK1
Goo, YA1
Pellegrini, M1
Chen, JN1
Damoiseaux, R1
Iruela-Arispe, ML1
Andrade, F1
Rafael, D1
Vilar-Hernández, M1
Montero, S1
Martínez-Trucharte, F1
Seras-Franzoso, J1
Díaz-Riascos, ZV1
Boullosa, A1
García-Aranda, N1
Cámara-Sánchez, P1
Arango, D1
Nestor, M1
Abasolo, I1
Sarmento, B1
Schwartz, S1

Other Studies

3 other studies available for niclosamide and Cells, Neoplasm Circulating

ArticleYear
Effects of salinomycin and niclosamide on small cell lung cancer and small cell lung cancer circulating tumor cell lines.
    Investigational new drugs, 2020, Volume: 38, Issue:4

    Topics: Antigens, CD; Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Humans; Lung Neop

2020
A High-Content Screen Identifies Drugs That Restrict Tumor Cell Extravasation across the Endothelial Barrier.
    Cancer research, 2021, 02-01, Volume: 81, Issue:3

    Topics: Animals; Cell Communication; Cell Line, Tumor; Cell Proliferation; Colforsin; Drug Screening Assays,

2021
Polymeric micelles targeted against CD44v6 receptor increase niclosamide efficacy against colorectal cancer stem cells and reduce circulating tumor cells in vivo.
    Journal of controlled release : official journal of the Controlled Release Society, 2021, 03-10, Volume: 331

    Topics: Cell Line, Tumor; Colorectal Neoplasms; Humans; Hyaluronan Receptors; Micelles; Neoplastic Cells, Ci

2021